D-168-2013 Class II Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- March 6, 2013
- Initiation Date
- December 17, 2012
- Termination Date
- May 3, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 324 vials
Product Description
EXPAREL (bupivacaine liposome injectable suspension), 1.3%, 266 mg/20 mL (13.3 mg/mL) single use vials, INVESTIGATIONAL USE. For Infiltration Only. Not for any other route of administration. Manufactured by Paelra Pharmaceuticals. Inc., San Diego, California, USA
Reason for Recall
Subpotent; bupivacaine
Distribution Pattern
Nationwide distribution: AZ, DC, FL, GA, MA, NJ, NY, OH, and TX.
Code Information
Lot #11-2005 Control #23542 Manufacture Date: 05Dec11 2011-L-009